Multidisciplinary Teams Ensure The Best Approach to Innovative Drug Delivery Technologies
At Bend Research, we craft multidisciplinary teams with our clients’ scientists so that we can align objectives to ensure the best path forward to advance difficult compounds. We make certain our clients have access to the skill sets and technologies they require by making the best people available to every project. It is this multidisciplinary team approach that enables us to provide in-depth scientific review of our clients’ most difficult drug delivery and development challenges. As a result, we are able to meet clients’ needs for science and engineering excellence, reliability, and rapid response.
Our vertically integrated structure and multidisciplinary teams enable us to streamline the development of world-class drug-delivery solutions. Every day our people talk directly to each other and to our clients, moving efficiently and quickly through various capabilities and technologies, all with the goal of advancing the best new medicines. It is these people who have pioneered advancements in new drug delivery platforms such as spray-dried dispersions, spearheaded formulation development to promote controlled release, and oversee our cGMP manufacturing.
Experts in Their Fields
Each of our employees is an expert in his or her own field, but they also share an exemplary work ethic, a global perspective on science, and a commitment to continual improvement. Of more than 200 employees, Bend Research has dozens of scientists with doctoral and advanced technical degrees.
Download the PDF below to view a breakdown of our staff disciplines:
Randy Wald was recently appointed to a 3 year termon theScientificAdvisor CommitteefortheEditors of JPharmSci®.
JPharmSci®’s Editorial Teamconsists of thirteenother Editors and has created a new advisor database consisting ofthe journal’s160 Editorial AdvisoryBoard members and approximately 450-500 “Scientific Advisors”. These 600-650 highly accomplished pharmaceutical scientists, whoare loyaland dedicated to the future success of JPharmSci®, will serve in the future as theprimary advisors to the journal’sEditorial Teamand as the primary reviewers of manuscripts submitted to JPharmSci®.
The responsibilities of these “Scientific Advisors to the Editors of JPharmSci®” include the following: (i) toadvise the journal’s EditorialTeam about thescope and direction of JPharmSci®;
(ii) toreview a minimum of four manuscriptsper year for JPharmSci®; and (iii) to be an advocatefor JPharmSci®in termsof recruiting manuscripts forthe journal amongst peers and bysubmitting at least one manuscript peryearfromtheirown laboratory.
Congratulations Randy !